What Is ULTHERA Prime Ultrasound Therapy?

The most common mistake when buying an ULTHERA Prime is treating it as a laser. It is not: it delivers micro-focused ultrasound, so it carries no laser class, no laser safety label and no…

What Is ULTHERA Prime Ultrasound Therapy?
Posted on by Dr. Jacklove

The most common mistake when buying an ULTHERA Prime is treating it as a laser. It is not: it delivers micro-focused ultrasound, so it carries no laser class, no laser safety label and no laser eyewear requirement — and the checks that matter instead are the transducer depths, the visualization, and the transducer count. Get those three right and the platform is predictable; treat it as a laser and you will be checking the wrong paperwork.

(Last modified date: October 3, 2026)

What the platform actually delivers

ULTHERA Prime is a micro-focused ultrasound system for non-surgical lifting. Energy is deposited at fixed depths rather than swept across the surface, and the manufacturer’s transducers are multi-patient-use parts that treat at three separate depths — superficial dermis at 1.5 mm, deep dermis at 3 mm, and SMAS/platysma at 4.5 mm. The clinical claim rests on that depth control: the target for lifting is the deeper plane, and the superficial depth exists to treat texture and the finer dermal layer.

The second capability is visualization. Merz Aesthetics describes the PRIME platform as the evolution of Ultherapy — the platform the company calls the gold standard for nonsurgical lifting — combining ultrasound technology with vivid real-time imaging; the manufacturer states that PRIME’s screen is 35% larger with a faster image refresh rate, a 2× larger ultrasound field, reduced visual noise, and imaging to a depth of up to 8 mm.

That imaging figure is the one to hold on to when you are shown a used unit. Eight millimetres of field depth is what lets an operator confirm the plane before depositing energy; a unit whose imaging is degraded can still fire, and will still sound normal while doing it.

Also check:  How Can You Build a Minimalist Neurovascular Cath Lab?

ULTHERA Ultherapy PRIME micro-focused ultrasound lifting platform

Four things to verify on any used unit

Nothing below needs a service engineer to check, and each one is a purchase-stopping item rather than a negotiating point.

Check What good looks like Why it decides the purchase
Transducer inventory, by depth 1.5 mm, 3.0 mm and 4.5 mm transducers present, with remaining line counts stated per transducer Transducers are the recurring cost and the only part that limits what you can treat. A platform without the 4.5 mm transducer cannot perform the lifting treatment it is bought for.
Remaining line count per transducer A figure for each transducer, not a total Multi-patient-use parts are consumed by delivered lines. A single aggregate number tells you nothing about which depth runs out first.
Image quality on the unit itself Layered tissue visible at depth on the built-in display, with stable, low-noise imaging Visualization is the safety mechanism: it is how the operator confirms the plane before energy is delivered.
Software and platform generation The generation and version stated in writing against the serial number PRIME is the evolution of the earlier Ultherapy platform, so the generation determines the imaging capability and the treatment interface, not just the cosmetics.

The transducer is also where the consumable economics live. Because the parts are multi-patient-use rather than single-use, the question is not only how many you own but how their remaining lines are scheduled across your caseload; the depth that runs out first is the one that constrains your treatment menu.

ULTHERA DS 10-1.5N ultrasound transducer for Ultherapy treatment

Why there is no laser class on this device

This matters because purchase checklists written for lasers do not apply. In the United States, laser products are regulated as light-emitting electronic products under 21 CFR Part 1040, with the general performance standard in § 1040.10, specific-purpose products in § 1040.11 and labelling requirements in § 1040.10(g). An ultrasound platform is not a laser product, so it has no Class I–IV designation and no laser warning label, and a supplier who quotes you a laser class for an ultrasound device has answered a different question.

Also check:  How Can AI Find Vetted Medical Equipment Suppliers?

What does apply is the general device side. Under 21 CFR Part 820, the Quality Management System Regulation, which incorporates ISO 13485 by reference, § 820.35 requires control of records and § 820.45 requires device labelling and packaging controls. For a refurbished or re-sold platform that means asking, against the serial number you are buying, for the device history record covering the work done, the labelling as it will be delivered, the packaging specification it was shipped against, and the performance verification for the treatment modality. Those are the documents that substitute for the laser certificate you are not going to receive.

A treatment-room model with the assumptions written down

Whether PRIME belongs in a room is a utilisation question, so model it rather than reading a payback claim. Assume three lifting sessions a week at an average ticket of $1,800, delivered in a 38-week working year: gross revenue is 3 × 1,800 × 38 = $205,200. Deduct transducer consumption at an assumed 20% of revenue ($41,040), room and staff time at an assumed 25% ($51,300), and the contribution before equipment cost is about $112,860.

Now stress the two variables that actually move. Drop to two sessions a week and gross revenue falls to $136,800, taking the contribution to roughly $75,240. Raise transducer consumption to 30% and it falls again. This is a model, not a measurement, and the inputs to replace with your own records are throughput and the transducer cost per session — which is precisely why the remaining line counts belong in the purchase decision rather than in a maintenance log.

FAQs

Is ULTHERA Prime a laser treatment?

No. It delivers micro-focused ultrasound, so it carries no laser class, no laser warning label and no laser eyewear requirement. Documentation duties sit under the general device quality-system rules rather than the laser product performance standard.

What depths does it treat?

The manufacturer’s transducers treat at three separate depths: superficial dermis at 1.5 mm, deep dermis at 3 mm, and SMAS/platysma at 4.5 mm. Each depth is a separate transducer, so the depths you own define the treatments you can offer.

Also check:  Can Standardizing Aortotomy Improve Graft Patency?

What should I check before buying a used unit?

The transducer inventory by depth, the remaining line count per transducer rather than in total, the image quality as displayed on the unit itself, and the platform generation stated in writing against the serial number.

What documents should arrive with a refurbished platform?

Under 21 CFR Part 820, a device history record covering the refurbishment, the labelling as delivered, the packaging specification, and performance verification for the treatment modality, all tied to the specific serial number.

How long do results last?

Duration is a clinical outcome that depends on the treatment plane, the patient and the number of sessions delivered, so it belongs in your own follow-up records rather than in a fixed figure taken from sales material.

References

Part of the Ultrasound Body Contouring guide.

Part of the Ultrasound Body Contouring guide.